JPRN-UMIN000009906已完成2 期
Safety and Clinical Outcomes of Percutaneous Cryoablation for Musculoskeletal Tumor: a Phase-II Clinical Study - Percutaneous Cryoablation for Musculoskeletal Tumor
Department of Radiology, Mie University School of Medicine0 个研究点目标入组 20 人开始时间: 2013年1月30日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Exclusion criteria is an abnormal coagulability as defined by platelet count of less than 50,000/mm3, and an international normalized ratio (INR) of greater than 1.5.
研究者
相似试验
已完成
2 期
Safety and Efficacy of Percutaneous Cryoablation for Thoracic MalignanciesPrimary lung cancer, metastatic lung cancer, mediastinal tumor, chest wall tumorJPRN-UMIN000014996School of Medicine, Keio University200
已完成
不适用
Safety cofirmatory study for Percutaneous cryoablation of vascular malformationsvascular malformationJPRN-UMIN000012194Okayama University Hospital9
已完成
1 期
Safety of Percutaneous Cryoablation in Patients with Painful Bone and Soft Tissue Tumors: A Single Center Prospective Study (SCIRO-1502)Painful bone and soft tissue tumorJPRN-UMIN000019077Okayama University Hospital10
尚未招募
不适用
Safety and feasibility of the use of cryoablation in patients with brain neoplasmbrain neoplasmbrain tumors1002765610019190NL-OMON53649Erasmus MC, Universitair Medisch Centrum Rotterdam30
已完成
1 期
Phase 1 Clinical Trial of Percutaneous Cryoablation for Painful Musculoskeletal TumorPainful Muscloskeletal tumor (osteoid osteoma, metastatic MSK tumor)JPRN-UMIN000027828Gunma University Hospital18